Silver Book Fact

To date, multiple genomewide comparisons of thousands of subjects with type 2 diabetes and controls without the disease have identified approximately twenty-five DNA variants that are significantly associated with type 2 diabetes. 

Spiegel, Allen M. and Meredith Hawkins. ‘Personalized Medicine’ To Identify Genetic Risks For Type 2 Diabetes And Focus Prevention: Can It Fulfill Its Promise?. Health Affairs. 2012; 31(1): 43-49. https://www.healthaffairs.org/doi/abs/10.1377/hlthaff.2011.1054?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed

Reference

Title
‘Personalized Medicine’ To Identify Genetic Risks For Type 2 Diabetes And Focus Prevention: Can It Fulfill Its Promise?
Publication
Health Affairs
Publisher
Project HOPE
Publication Date
2012
Authors
Spiegel, Allen M. and Meredith Hawkins
Volume & Issue
Volume 31, Issue 1
Pages
43-49
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • Projected change in 3-year diabetes-related costs and 10-year disease event rates among Medicaid recipients participating in a diabetes self-management education program consisting of a 60 minute initial individual assessment of…  
  • Disease Management Program Increases Use of Diabetes Medicines and Reduces Total Health Spending  
  • Average direct medical costs over time, in 2001, for 194 participants in a community-based pharmaceutical care services program for patients with diabetes.  
  • Economics of DR Treatment
    Laser treatment plus a VEGF inhibitor achieved an incremental cost-effectiveness ratio of $12,410 per quality adjusted life year in patients with DME.  
  • Following the current path, diabetes cases will increase by 52.9% between 2003 and 2023. If an alternative path is taken, there will be 13.3% (2.8 million) fewer diabetes cases.